Taylor Morrison Home (TMHC) Q2 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2024 earnings summary
8 Jul, 2026Executive summary
Q2 2024 saw 3,200 home closings at an average price of $600,000, with adjusted EPS of $1.97 and adjusted gross margin of 23.9%.
Net sales orders increased 3% year-over-year to 3,111, with a monthly absorption pace of 3 per community and a 6% increase in community count.
Home closings revenue was $1.9 billion, down 4% year-over-year due to a 6% drop in average closing price, partially offset by higher closings.
Book value per share grew to $52, and backlog at quarter end was 6,256 homes valued at $4.2 billion.
Repurchased 1.7 million shares for $105 million in Q2; total liquidity stood at $1.3 billion.
Financial highlights
Total Q2 2024 revenue was $1.99 billion, down 3.4% year-over-year; adjusted net income was $211 million, and adjusted diluted EPS was $1.97.
Home closings gross margin was 23.8% reported, 23.9% adjusted for inventory impairment.
SG&A as a percentage of home closings revenue increased to 10.2% from 9.2% a year ago.
EBITDA for Q2 2024 was $303 million (15.2% of revenue); adjusted EBITDA was $325 million (16.3% of revenue).
Net homebuilding debt to capitalization was 22.8%, up from 15.4% a year ago.
Outlook and guidance
Full-year 2024 home closings expected between 12,600 and 12,800 at a gross margin of ~24%.
Average closing price for 2024 forecasted at $600,000–$610,000; SG&A as a percentage of revenue expected in the high-9% range.
Land and development spend projected at $2.3–$2.5 billion; share repurchases to total ~$300 million.
Q3 2024 guidance: ~3,200 home closings, average price ~$600,000, gross margin ~24%, effective tax rate ~25%.
Long-term targets include 10%+ annual home closings growth, low-to-mid 20% gross margins, and mid-to-high teens ROE.
Latest events from Taylor Morrison Home
- Q3 2025 saw $2.0B revenue, $201M net income, and 22.1% gross margin with strong liquidity.TMHC
Q3 20259 Jul 2026 - Aims for 20,000 closings by 2028 with digital innovation, capital discipline, and high-teen ROE.TMHC
Investor Day 20258 Jul 2026 - Q3 net income up 54% to $251M, with strong revenue, margin gains, and robust guidance.TMHC
Q3 20248 Jul 2026 - Q2 2025 revenue rose 2% to $2.03B, net income $194M, and net sales orders declined 12%.TMHC
Q2 20258 Jul 2026 - Stockholders to vote on $72.50/share cash merger with Berkshire Hathaway, board recommends approval.TMHC
Proxy filing23 Jun 2026 - Shareholders to vote on Berkshire Hathaway's $72.50 per share all-cash acquisition, with board support.TMHC
Proxy filing12 Jun 2026 - Taylor Morrison to be acquired by Berkshire Hathaway, pending shareholder approval.TMHC
Proxy filing12 Jun 2026 - Definitive acquisition agreement reached; shareholders to vote, with no immediate business changes.TMHC
Proxy filing5 Jun 2026 - Definitive agreement for acquisition by Berkshire Hathaway, pending shareholder approval.TMHC
Proxy filing5 Jun 2026